As of now, personalized cancer vaccines are primarily available through clinical trials. However, the encouraging results from early-phase studies are driving efforts to bring these therapies to the wider patient population. Patients interested in personalized cancer vaccines should consult with their oncologists to explore eligibility for ongoing trials.
